The Butenolide Signaling Molecules SRB1 and SRB2 Induce Lankacidin and Lankamycin Production in Streptomyces rochei

Abstract

New signaling molecules that induce lankacidin and lankamycin production in Streptomyces rochei were extracted from the culture filtrate and purified by Sephadex LH20 and silica gel chromatography with the help of bioassay. Chiral HPLC and ESI‐MS analyses indicated the presence of two active components—SRB1 and SRB2—and their molecular formulas were established to be C₁₅H₂₄O₅ and C₁₆H₂₆O₅, respectively. By extensive NMR analysis, SRB1 and SRB2 were determined to be 2‐(1′‐hydroxy‐6′‐oxo‐8′‐methylnonyl)‐3‐methyl‐4‐hydroxybut‐2‐en‐1,4‐olide and 2‐(1′‐hydroxy‐6′‐oxo‐8′‐methyldecyl)‐3‐methyl‐4‐hydroxybut‐2‐en‐1,4‐olide, respectively. These structures were finally confirmed by chemical synthesis and the absolute configuration at C‐1′ was determined to be R in each case. The synthetic 1′R isomers induced production of lankacidin and lankamycin at around 40 nM concentrations. SRB1 and SRB2 are therefore distinct from the well‐known 2,3‐disubstituted γ‐butyrolactone molecules such as A‐factor, virginia butanolide, and SCB1 and and belong, like avenolide, recently isolated from Streptomyces avermitilis, to the γ‐butenolide family.